RBC Capital Markets reiterated their positive stance on Alnylam Pharmaceuticals (NASDAQ:ALNY), maintaining an Outperform rating and a price target of $300.00. According to InvestingPro data, analyst ...

RBC Capital analyst Gerard Cassidy maintained a Hold rating on Goldman Sachs Group (GS – Research ... Investment Banking, Global Markets, Asset Management, and Consumer & Wealth Management.

In a report released today, Niraj Shah from Goldman Sachs maintained a Buy rating on Incitec Pivot Limited (ICPVF – Research Report), with a ...

RBC Capital Markets head of global energy research Greg Pardy has made two changes to his Global Energy Best Ideas list, ...

Keefe, Bruyette & Woods analyst David Konrad reiterated an Outperform rating on the shares of Goldman Sachs Group Inc ... those looking to invest in capital markets, per the analyst.

Goldman Sachs would consider acquisitions in asset and wealth management, but would be highly selective about any deal, CEO ...

Aaron Lamshed moved up to head of ECM for Goldman Sachs in Australia and New Zealand in 2023. Street Talk understands the Wall Street firm’s head of equity capital markets and head of ...

Citi (C), JPMorgan Chase (JPM), Goldman Sachs (GS), and Wells Fargo (WFC) report on Wednesday, while Bank of America (BAC) and Morgan Stanley (MS) release results on Thursday. RBC Capital markets ...

Hedge funds last week jettisoned global stocks and added bets they would decline, said Goldman Sachs , just before U.S.

Goldman Sachs exceeds revenue expectations in trading ... it is still considered an attractive option for those looking to invest in capital markets, per the analyst. Due to robust revenues ...